Is TB-500 FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether TB-500 (Thymosin Beta-4) is FDA approved and how it is commonly categorized.
Overview
TB-500 is a synthetic peptide version of thymosin beta-4, a naturally occurring protein involved in tissue repair and cellular migration. It has primarily been studied in preclinical and experimental settings.
FDA Status Details
TB-500 is classified as Not FDA Approved. It has not been approved by the FDA for any medical indication or prescription use.
Brand Names & Variants
TB-500 does not have any FDA-approved brand-name products. It is not marketed as an approved pharmaceutical drug in the United States.
Compounded & Private Label Considerations
Products marketed as TB-500 are often labeled for “research use only” and may be sold through unregulated channels. These products are not reviewed or approved by the FDA for safety, effectiveness, or quality.
Search Another Drug or Compound
Use DrugStatusIndex to review regulatory status information.